Yang F, Li A, Liu H, & Zhang H. (2018). Gastric cancer combination therapy: Synthesis of a hyaluronic acid and cisplatin containing lipid prodrug coloaded with sorafenib in a nanoparticulate system to exhibit enhanced anticancer efficacy and reduced toxicity. Dove Medical Press.
Chicago Style (17th ed.) CitationYang F, Li A, Liu H, and Zhang H. Gastric Cancer Combination Therapy: Synthesis of a Hyaluronic Acid and Cisplatin Containing Lipid Prodrug Coloaded with Sorafenib in a Nanoparticulate System to Exhibit Enhanced Anticancer Efficacy and Reduced Toxicity. Dove Medical Press, 2018.
MLA (9th ed.) CitationYang F, et al. Gastric Cancer Combination Therapy: Synthesis of a Hyaluronic Acid and Cisplatin Containing Lipid Prodrug Coloaded with Sorafenib in a Nanoparticulate System to Exhibit Enhanced Anticancer Efficacy and Reduced Toxicity. Dove Medical Press, 2018.